Drug · DIN 02236841
LEVAQUIN
No: no longer authorized
The company stopped selling it and its DIN was cancelled. A cancellation is most often a business decision; the record does not say why.
Status Cancelled Post Market since October 27, 2014; first marketed November 28, 1997.
- Drug Identification Number (DIN)
- 02236841
- Company (DIN owner)
- Janssen Inc.Toronto, Ontario, Canada
- Schedule
- Prescription
- Dosage form
- Tablet
- Route
- Oral
- Therapeutic class (ATC)
- Levofloxacin J01MA12
- Class
- Human
- Record last updated
- June 25, 2026
Active ingredients
As listed in the Drug Product Database.
| Ingredient | Strength | Per |
|---|---|---|
| LEVOFLOXACIN | 250 MG |
Notices of Compliance
Health Canada approvals that name this DIN.
- August 20, 2014: NOC 15986Supplement to a New Drug Submission (SNDS) · Removal of references to the discontniued iv formulation from pm
- November 14, 1997: NOC 3909New Drug Submission (NDS)